Table 3 List of NCCN-recommended systemic anticancer therapies
NCCN-recommended systemic cancer therapy |
|---|
Bevacizumab |
Carboplatin |
Cyclophosphamide |
Dacarbazine |
Dactinomycin |
Docetaxel |
Doxorubicin/pegylated liposomal doxorubicin |
Epirubicin |
Eribulin |
Etoposide |
Gemcitabine |
Ifosfamide |
Irinotecan |
Paclitaxel |
Pazopanib |
Sorafenib |
Sunitinib |
Temozolomide |
Topotecan |
Trabectedin |
Vincristine |
Vinorelbine |